Effect of Abdominal Massage on Excretory Activity and Pulmonary Function Tests in Patients After Surgery

Effect of Abdominal Massage on Excretory Activity and Pulmonary Function Tests in Patients With Partial Hip Replacement

This study is aimed to determine the effect of abdominal massage on excretory activity and pulmonary function tests (PFT) in patients undergoing PKP.

Study Overview

• Status: Completed
• Conditions: Intraabdominal Pressure
• Intervention / Treatment: Other: Abdominal massage

Detailed Description

Methods: The research will be carried out with 78 patients who underwent partial hip replacement. Patients were assigned to study (abdominal massage) and control groups by randomization. Abdominal massage will be applied to the patients at least 30 minutes after the morning and evening meals (08:30 in the morning, 20:30 in the evening) for 15 minutes, similar to the literature. Patients' data will be collected 15 minutes before and after the application of abdominal massage. Within the scope of the patient's data, information on pulmonary function test values, intra-abdominal pressure value and excretory activities will be collected. Abdominal massage will start in the evening of the day the patient is transferred to the clinic (20:30), and will be terminated when the patient defecates. No treatment will be applied to the patients in the control group. The data recorded before and after the abdominal massage in the study group will be recorded in the Excretory Activity Form and the Pulmonary Function Test Form as a result of the measurements made at the same time in the control group.

• Study Type: Interventional
• Enrollment (Actual): 78
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Mersin, Turkey
    • Mersin Univercity

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 60 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Having a urinary catheter for at least one day after surgery,
• Discharged at least 48 hours after surgery,
• Do not have any condition for which abdominal massage is contraindicated (inflammatory bowel disease, presence of abdominal tumor, surgical intervention or radiotherapy to the abdominal region, presence or suspicion of ileus, and pregnancy),
• No diagnosis of chronic constipation made by a physician,
• Who has not developed any respiratory tract complications (atelectasis, pneumonia, etc.) due to surgical intervention,
• No chronic respiratory disease (chronic obstructive pulmonary disease, pulmonary hypertension, sleep apnea syndrome, asthma, chronic bronchitis, cystic fibrosis, occupational lung diseases, etc.),
• Patients who do not have problems in transition to oral feeding and who can be fed orally will be included in the study.

Exclusion Criteria:

• Urinary catheter removed within the first day after surgery,
• Discharged before 48 hours after surgery,
• Any condition in which abdominal massage is contraindicated (inflammatory bowel disease, presence of abdominal tumor, surgical intervention or radiotherapy to the abdominal region, presence or suspicion of ileus, and pregnancy),
• Having a diagnosis of constipation made by a physician,
• Having any respiratory complications (atelectasis, pneumonia, etc.) developed due to surgical intervention,
• Having chronic respiratory disease (chronic obstructive pulmonary disease, pulmonary hypertension, sleep apnea syndrome, asthma, chronic bronchitis, cystic fibrosis, occupational lung diseases, etc.),
• Patients who have problems in the transition to oral feeding and cannot be fed orally will not be included in the study.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control group; The control group will be received routine treatment and care in the unit.
Experimental: Abdominal massage group; Abdominal massage will be applied to the experimental group 2 times a day, morning and evening, until defecation, starting in the evening of the first day after the surgical intervention.	Other: Abdominal massage; Abdominal massage will be applied to patients at least 30 minutes after morning and evening meals (8:30 in the morning, 20:30 in the evening) for 15 minutes each, similar to the literature [33,34,38]. Data of the patients will be collected again 15 minutes after the application of abdominal massage (09:00-09:15 in the morning, 21:00-21:15 in the evening). Abdominal massage will start in the evening of the day the patient is transferred to the clinic (20:30), and will be terminated when the patient defecates. In order to stimulate bowel movements, four basic movements will be used in the abdominal massage to be applied clockwise: superficial effusion, deep effusion, petrissage, and vibration.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Intra-abdominal Pressure Value	Intra-abdominal pressure measurement will be performed using the existing urinary catheter in the patient. This measurement method, which is performed through the bladder, is accepted as the gold standard for intra-abdominal pressure measurement because it is an easy-to-apply and minimally invasive procedure [25,43]. The investigator (CK) will measure the intra-abdominal pressure via a sterile single-transducer pressure monitoring set, which will be attached to the patient's urinary catheter at one end and to a portable monitor capable of measuring pressure at the other end. The measured value will be recorded in Excretory Activities Form.	up to first defecation an average of 3 days
Return time of bowel sounds	The return time of bowel sounds will be evaluated morning and evening and recorded in the Excretory Activities Form.	up to first defecation an average of 3 days
Number of bowel sounds	The number of bowel sounds will be evaluated morning and evening and recorded in the Excretory Activities Form.	up to first defecation an average of 3 days
First defecation time	The time to first defecation will be asked morning and evening after surgery and recorded in the Excretory Activities Form.	up to first defecation an average of 3 days
Amount of laxative use	The amount of drug use to assist with defecation will be evaluated morning and evening and recorded in the Excretory Activities Form.	up to first defecation an average of 3 days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pulmonary Function Tests- FVC	The FVC value obtained using the Respiratory Function Test device will be recorded in the Pulmonary Function Tests Form.	up to first defecation an average of 3 days
Pulmonary Function Tests- FEV-1	The FEV-1 value obtained using the Respiratory Function Test device will be recorded in the Pulmonary Function Tests Form.	up to first defecation an average of 3 days
Pulmonary Function Tests- FEV1/FVC	The FEV1/FVC value obtained using the Respiratory Function Test device will be recorded in the Pulmonary Function Tests Form.	up to first defecation an average of 3 days

Collaborators and Investigators

• Sponsor: Mersin University
• Investigators: Study Director: Gülay Altun Uğraş, doctorate, Mersin University

Study record dates

Study Major Dates

• Study Start (Actual): December 30, 2021
• Primary Completion (Actual): September 30, 2022
• Study Completion (Actual): September 30, 2022

Study Registration Dates

• First Submitted: October 27, 2021
• First Submitted That Met QC Criteria: November 16, 2021
• First Posted (Actual): November 19, 2021

Study Record Updates

• Last Update Posted (Actual): March 15, 2023
• Last Update Submitted That Met QC Criteria: March 14, 2023
• Last Verified: March 1, 2023

More Information

Terms related to this study

• Keywords: Nursing care; Abdominal massage; Pulmonary function tests; Defecation; Partial hip replacement; Excretory activity
• Other Study ID Numbers: MersinUCKANAT-01

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No